학술논문
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions
Document Type
article
Author
Alessandro Fiocchi, MD; Antonio Bognanni, MD; Jan Brożek, MD, PhD; Motohiro Ebisawa, MD, PhD; Holger Schünemann, MD; Ignacio J. Ansotegui, MD, PhD; Stefania Arasi, MD; Amal H. Assa'ad, MD; Sami L. Bahna, MD, DrPH; Roberto Berni Canani, MD, PhD; Martin Bozzola, MD; Derek Chu; Lamia Dahdah, MD; Christophe Dupont, MD, PhD; Ramon Targino Firmino; Elena Galli, MD, PhD; Rose Kamenwa, MD; Gideon Lack, MD; Haiqi Li, MD; Alberto Martelli, MD; Anna Nowak-Węgrzyn, MD; Nikolas G. Papadopoulos, MD, PhD; Ruby Pawankar, MD, PhD; Maria Said, RN; Mario Sánchez-Borges; Raanan Shamir, PhD; Jonathan M. Spergel, MD, PhD; Hania Szajewska, MD; Luigi Terracciano, MD; Yvan Vandenplas, MD, PhD; Carina Venter, PhD, RD; Amena Warner; Susan Waserman, MD, MSc; Gary W.K. Wong, MD
Source
World Allergy Organization Journal, Vol 15, Iss 1, Pp 100609- (2022)
Subject
Language
English
ISSN
1939-4551
Abstract
Since the World Allergy Organization (WAO) Diagnosis and Rationale against Cow's Milk Allergy (DRACMA) Guidelines were published 10 years ago, new evidence has accumulated about the diagnosis, therapy, and specific immunotherapy for cow's milk allergy (CMA). For this reason, WAO has felt the need to update the guidelines.We introduce here this update. The new DRACMA guidelines aim to comprehensively address the guidance on diagnosis and therapy of both IgE non-IgE-mediated forms of cow's milk allergy in children and adults. They will be divided into 18 chapters, each of which will be dedicated to an aspect. The focus will be on the meta-analyzes and recommendations that will be expressed for the 3 most relevant clinical aspects: (a) the diagnostic identification of the condition; (b) the choice of the replacement formula in case of CMA in infancy when the mother is not able to breastfeed, and (c) the use of specific immunotherapy for cow's milk protein allergy.